Literature DB >> 22851769

Pari passu dimers of dimers.

Mark X Sliwkowski1.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22851769      PMCID： PMC3421198          DOI： 10.1073/pnas.1209959109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  16 in total

1.  Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth.

Authors:  David B Agus; Robert W Akita; William D Fox; Gail D Lewis; Brian Higgins; Paul I Pisacane; Julie A Lofgren; Charles Tindell; Douglas P Evans; Krista Maiese; Howard I Scher; Mark X Sliwkowski
Journal:  Cancer Cell       Date:  2002-08       Impact factor: 31.743

2.  Functional isolation of activated and unilaterally phosphorylated heterodimers of ERBB2 and ERBB3 as scaffolds in ligand-dependent signaling.

Authors:  Qian Zhang; Euisun Park; Kian Kani; Ralf Landgraf
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

3.  The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors.

Authors:  Thomas P J Garrett; Neil M McKern; Meizhen Lou; Thomas C Elleman; Timothy E Adams; George O Lovrecz; Michael Kofler; Robert N Jorissen; Edouard C Nice; Antony W Burgess; Colin W Ward
Journal:  Mol Cell       Date:  2003-02       Impact factor: 17.970

4.  Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.

Authors:  P M Guy; J V Platko; L C Cantley; R A Cerione; K L Carraway
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

Review 5.  Untangling the ErbB signalling network.

Authors:  Y Yarden; M X Sliwkowski
Journal:  Nat Rev Mol Cell Biol       Date:  2001-02       Impact factor: 94.444

6.  A single ligand is sufficient to activate EGFR dimers.

Authors:  Ping Liu; Thomas E Cleveland; Samuel Bouyain; Patrick O Byrne; Patti A Longo; Daniel J Leahy
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-14       Impact factor: 11.205

7.  Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab.

Authors:  Hyun-Soo Cho; Karen Mason; Kasra X Ramyar; Ann Marie Stanley; Sandra B Gabelli; Dan W Denney; Daniel J Leahy
Journal:  Nature       Date:  2003-02-13       Impact factor: 49.962

8.  Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3.

Authors:  Chi-Hong B Chen; George A Chernis; Van Q Hoang; Ralf Landgraf
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-21       Impact factor: 11.205

9.  Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex.

Authors:  Matthew C Franklin; Kendall D Carey; Felix F Vajdos; Daniel J Leahy; Abraham M de Vos; Mark X Sliwkowski
Journal:  Cancer Cell       Date:  2004-04       Impact factor: 31.743

Review 10.  An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors.

Authors:  Antony W Burgess; Hyun-Soo Cho; Charles Eigenbrot; Kathryn M Ferguson; Thomas P J Garrett; Daniel J Leahy; Mark A Lemmon; Mark X Sliwkowski; Colin W Ward; Shigeyuki Yokoyama
Journal:  Mol Cell       Date:  2003-09       Impact factor: 17.970
View more
  2 in total

1.  Insights into HER2 signaling from step-by-step optimization of anti-HER2 antibodies.

Authors:  Wenyan Fu; Yuxiao Wang; Yunshan Zhang; Lijuan Xiong; Hiroaki Takeda; Li Ding; Qunfang Xu; Lidong He; Wenlong Tan; Augus N Bethune; Lijun Zhou
Journal:  MAbs       Date:  2014-04-16       Impact factor: 5.857

2.  Coarse-grained molecular simulation of epidermal growth factor receptor protein tyrosine kinase multi-site self-phosphorylation.

Authors:  John G Koland
Journal:  PLoS Comput Biol       Date:  2014-01-16       Impact factor: 4.475
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.